By accompanying the VILA 2025 National Scientific Conference on Pulmonary Diseases, held in Can Tho in November 2025 and attended by more than 1,000 respiratory specialists, Imexpharm continues to reaffirm its long-term commitment to respiratory health for the community.
A Large-Scale Scientific Forum for Vietnam’s Respiratory Sector
As respiratory diseases continue to increase and pose significant challenges to the healthcare system, updating medical knowledge and enhancing professional capacity for physicians have become increasingly important. In this context, the Vietnam Lung Association, in collaboration with the National Lung Hospital and the National Tuberculosis Control Program, organized the VILA 2025 National Scientific Conference on Pulmonary Diseases in Can Tho in November, in a hybrid format combining in-person and online participation. The conference attracted over 1,000 physicians specializing in respiratory medicine and related fields.
Mr. Nguyen Dang Nam (left), Marketing Manager at Imexpharm, poses for a photo with the company's colleagues at the 11th National Scientific Conference on Pulmonary Diseases in Can Tho, November 2025. Photo: Imexpharm.
As a reputable annual scientific event, VILA 2025 focused on up-to-date and practical topics, reflecting key issues in the diagnosis, treatment, and management of respiratory diseases. Scientific presentations delivered by leading experts provided in-depth professional perspectives and contributed to addressing current challenges in clinical practice across healthcare facilities.
Beyond serving as an academic forum, VILA 2025 also functioned as a national platform for connecting the respiratory medical community. Through discussion sessions and professional exchanges, the conference facilitated the sharing of practical experience, strengthened collaboration, and promoted a shared commitment to improving the quality of patient care in a sustainable manner.
Imexpharm’s Continued Support for Scientific and Medical Education
By participating in VILA 2025, Imexpharm continued its active presence in scientific activities within the respiratory sector. Its ongoing partnership with the Vietnam Lung Association in annual professional conferences reflects the company’s sustained engagement and long-term commitment to medical education, scientific research, and the enhancement of treatment quality in respiratory care.
A scientific session featuring physician presentations at the 11th National Scientific Conference on Pulmonary Diseases in Can Tho, November 2025. Photo: Imexpharm.
At VILA 2025, Imexpharm not only participated as a sponsor but also actively implemented activities to introduce treatment solutions through exhibition booths, professional materials, and scientific content shared during the conference. This provided an opportunity for the company to engage with physicians on real-world treatment needs while staying updated on emerging trends in clinical practice.
Within the framework of the event, Imexpharm introduced its portfolio of high-technology antibiotic products manufactured to EU-GMP standards, notably products containing Colistin in various dosage forms such as lyophilized powder for injection and inhalation, offering healthcare professionals additional therapeutic options for the management of hospital-acquired infections.
Through its participation in VILA 2025, Imexpharm continues to affirm its orientation of partnering with the medical community in sharing solutions and fulfilling its mission of “providing highly effective solutions for community health.”